Skip to main content
padlock icon - secure page this page is secure

Free Content Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells

Download Article:
 Download
(PDF)
 
Summary

CD3- and CD28-activated T cells expanded for 12 days ex vivo to produce suicide gene-modified T cells are hyporesponsive to alloantigens. To investigate whether this impaired alloreactivity is a result of preferential expansion of regulatory T (Treg) cells, we compared peripheral blood mononuclear cells (PBMC) activated with CD3 and CD28 antibodies co-immobilized on beads and expanded for 12 days with interleukin (IL)-2 (CoCD3/CD28 cells) to the respective unactivated PBMC in terms of proliferation, cytokine production, and expression of Treg markers [cytotoxic T-lymphocyte antigen 4 (CTLA4), glucocorticoid-induced tumour necrosis factor receptor (GITR) and forkhead box P3 (FoxP3)] after allostimulation. Alloreactive cells were identified by carboxyfluoresceine succinimidyl ester staining dilution. Alloreactive cells in CoCD3/CD28 cells had a lower proliferative response and a lower potential for IL-2 and interferon-γ secretion than did those in PBMC, demonstrating a functional impairment of alloreactive cells during ex vivo expansion. Expression of Treg markers transiently increased during ex vivo expansion and was unaffected by depletion of CD25+ cells (containing Treg cells) before ex vivo PBMC expansion. Such prior CD25+ depletion did not restore the alloreactivity of CoCD3/CD28 cells. After allostimulation, expression of Treg markers was restricted to proliferative (alloreactive) cells among PBMC or CoCD3/CD28 cells. Lastly, CD4+ CD25+ cells purified from CoCD3/CD28 cells lacked suppressive activity when used as a third party, in contrast to CD4+ CD25+ cells purified from PBMC. In conclusion, the impaired alloreactivity of T cells expanded ex vivo is not a result of preferential Treg cell expansion and/or enhanced suppressive Treg activity.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: adoptive cellular immunotherapy; alloreactivity; cellular therapy; cultured cells; regulatory T cells

Document Type: Research Article

Affiliations: Invitrogen Corporation, Carlsbad, CA, USA

Publication date: November 1, 2008

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more